Pin Wang
- Immunology top 1%
- Immunotherapy and Immune Responses 22
- Immune Cell Function and Interaction 19
- Oncology top 1%
- CAR-T cell therapy research 43
- Cancer Research top 2%
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 9
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 35
- Advanced biosensing and bioanalysis techniques 10
- CRISPR and Genetic Engineering 8
-
- Virus-based gene therapy research 36
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesChinaJapan
In The Last Decade
Pin Wang
136 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Immunology 1.8k
- Oncology 2.0k
- Cancer Research 907
- Biomaterials 770
- Molecular Biology 2.9k
Countries citing papers authored by Pin Wang
This map shows the geographic impact of Pin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pin Wang more than expected).
Fields of papers citing papers by Pin Wang
This network shows the impact of papers produced by Pin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pin Wang. The network helps show where Pin Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignanciesbreakdown → | 2025 | 23 |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 16 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 23 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 52 | |
| 12 | 2021 | 33 | |
| 13 | 2020 | 13 | |
| 14 | 2018 | 143 | |
| 15 | 2017 | 252 | |
| 16 | 2017 | 34 | |
| 17 | 2017 | 11 | |
| 18 | 2011 | 35 | |
| 19 | 2008 | 36 | |
| 20 | 2006 | 122 |
About Pin Wang
Pin Wang is a scholar working on Immunology, Oncology, Genetics, Virology and Biomaterials, having authored 141 papers that have together received 6.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (43 papers), Virus-based gene therapy research (36 papers), RNA Interference and Gene Delivery (35 papers), Immunotherapy and Immune Responses (22 papers), Immune Cell Function and Interaction (19 papers), Advanced biosensing and bioanalysis techniques (10 papers), Nanoparticle-Based Drug Delivery (9 papers) and CRISPR and Genetic Engineering (8 papers). The work is most often cited by research in Immunology (1.8k citations), Oncology (2.0k citations), Cancer Research (907 citations), Biomaterials (770 citations) and Molecular Biology (2.9k citations). Pin Wang has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Yarong Liu, Kye‐Il Joo, Li Lin, Xuetao Cao, Jin Hou, Biliang Hu, Zhugang Wang, Xingguang Liu, Feng Ma and Elizabeth L. Siegler. Their work appears in journals such as Human Gene Therapy, Molecular Therapy, Nature Communications, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.